OPRX vs. GMED
OPRX (OptimizeRx Corporation) and GMED (Globus Medical, Inc.) are both stocks. Both are in the Healthcare sector — OPRX in Health Information Services, GMED in Medical Devices. Over the past 10 years, OPRX returned 18.70%/yr vs 12.86%/yr for GMED. Their 0.17 correlation means their historical movements had little consistent relationship.
Performance
OPRX vs. GMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OPRX achieves a -50.65% return, which is significantly lower than GMED's -9.76% return. Over the past 10 years, OPRX has outperformed GMED with an annualized return of 18.70%, while GMED has yielded a comparatively lower 12.86% annualized return.
OPRX
- 1D
- -3.51%
- 1M
- -0.49%
- 6M
- -43.77%
- YTD
- -50.65%
- 1Y
- -52.06%
- 3Y*
- -24.56%
- 5Y*
- -35.75%
- 10Y*
- 18.70%
- ALL TIME*
- 15.10%
GMED
- 1D
- -1.83%
- 1M
- 3.73%
- 6M
- -13.11%
- YTD
- -9.76%
- 1Y
- 49.71%
- 3Y*
- 10.13%
- 5Y*
- -1.08%
- 10Y*
- 12.86%
- ALL TIME*
- 13.68%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $96.46M | $126.87M | $149.45M | |
| $1.30M | $1.68M | $2.32M |
OPRX vs. GMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
OPRX OptimizeRx Corporation | -50.65% | 152.26% | -66.04% | -14.82% | -72.95% | 99.33% | 203.41% | -6.38% | 598.73% | 93.83% |
GMED Globus Medical, Inc. | -9.76% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 36.04% | 5.30% | 65.66% |
Correlation
The correlation between OPRX and GMED is 0.28, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.28 |
Correlation (3Y) Balances recent behavior with more history. | 0.25 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.33 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.24 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2012 | 0.17 |
The correlation between OPRX and GMED shifts across timeframes, from 0.17 (all time) to 0.33 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
OPRX:
$113.53M
GMED:
$10.63B
OPRX:
$0.36
GMED:
$4.28
OPRX:
16.86
GMED:
18.39
OPRX:
0.03
GMED:
0.19
OPRX:
1.07
GMED:
3.48
OPRX:
0.88
GMED:
2.30
OPRX:
$107.35M
GMED:
$3.10B
OPRX:
$70.86M
GMED:
$1.58B
OPRX:
$16.55M
GMED:
$803.34M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OPRX vs. GMED — Risk / Return Rank
OPRX
GMED
OPRX vs. GMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for OptimizeRx Corporation (OPRX) and Globus Medical, Inc. (GMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| OPRX | GMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.68 | ||
| Sortino ratioReturn per unit of downside risk | -3.05 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.26 | -0.36 |
| Calmar ratioReturn relative to maximum drawdown | -0.66 | 2.26 | -2.92 |
| Martin ratioReturn relative to average drawdown | -0.99 | 4.92 | -5.91 |
Loading charts...
Drawdowns
OPRX vs. GMED - Drawdown Comparison
The maximum OPRX drawdown since its inception was -99.32%, which is greater than GMED's maximum drawdown of -47.91%. Use the drawdown chart below to compare losses from any high point for OPRX and GMED.
Loading charts...
Drawdown Indicators
| OPRX | GMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.32% | -47.91% | -51.41% |
Max Drawdown (1Y)Largest decline over 1 year | -79.06% | -22.10% | -56.96% |
Max Drawdown (3Y)Largest decline over 3 years | -79.06% | -44.40% | -34.66% |
Max Drawdown (5Y)Largest decline over 5 years | -96.10% | -47.91% | -48.19% |
Max Drawdown (10Y)Largest decline over 10 years | -96.10% | -47.91% | -48.19% |
Current DrawdownCurrent decline from peak | -93.83% | -18.62% | -75.21% |
Average DrawdownAverage peak-to-trough decline | -60.80% | -15.35% | -45.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 52.76% | 10.13% | +42.63% |
Volatility
OPRX vs. GMED - Volatility Comparison
The current volatility for OptimizeRx Corporation (OPRX) is 9.79%, while Globus Medical, Inc. (GMED) has a volatility of 12.47%. This indicates that OPRX experiences smaller price fluctuations and is considered to be less risky than GMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OPRX | GMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.79% | 12.47% | -2.68% |
Volatility (6M)Calculated over the trailing 6-month period | 53.13% | 26.28% | +26.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.74% | 49.44% | +28.30% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 76.03% | 38.45% | +37.58% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 114.58% | 35.41% | +79.17% |
Dividends
OPRX vs. GMED - Dividend Comparison
Neither OPRX nor GMED has paid dividends to shareholders.
Financials
OPRX vs. GMED - Financials Comparison
This section allows you to compare key financial metrics between OptimizeRx Corporation and Globus Medical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
OPRX vs. GMED - Profitability Comparison
OPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, OptimizeRx Corporation reported a gross profit of 14.93M and revenue of 19.84M. Therefore, the gross margin over that period was 75.3%.
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.
OPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, OptimizeRx Corporation reported an operating income of 396.00K and revenue of 19.84M, resulting in an operating margin of 2.0%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.
OPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, OptimizeRx Corporation reported a net income of -495.00K and revenue of 19.84M, resulting in a net margin of -2.5%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.
Frequently Asked Questions
OPRX and GMED have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GMED has higher volatility (12.47%) compared to OPRX (9.79%). In terms of maximum drawdown, OPRX dropped -99.32% vs GMED's -47.91%.
GMED currently has the higher Sharpe Ratio (1.01 vs -0.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OPRX and GMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer